Amarin Corporation/$AMRN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Amarin Corporation
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Ticker
$AMRN
Sector
Primary listing
Industry
Biotechnology
Headquarters
Dublin 2, Ireland
Employees
-
ISIN
US0231114044
Website
AMRN Metrics
BasicAdvanced
$335M
-
-$4.40
0.67
-
Price and volume
Market cap
$335M
Beta
0.67
52-week high
$17.18
52-week low
$8.32
Average daily volume
134K
Financial strength
Current ratio
3.529
Quick ratio
2.392
Long term debt to equity
1.676
Total debt to equity
2.183
Interest coverage (TTM)
-8,356.43%
Profitability
EBITDA (TTM)
-55.514
Gross margin (TTM)
51.88%
Net profit margin (TTM)
-41.07%
Operating margin (TTM)
-27.32%
Effective tax rate (TTM)
-7.00%
Management effectiveness
Return on assets (TTM)
-5.06%
Return on equity (TTM)
-17.25%
Valuation
Price to revenue (TTM)
1.557
Price to book
0.71
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-10.795
Free cash flow yield (TTM)
-9.26%
Free cash flow per share (TTM)
-149.98%
Growth
Revenue change (TTM)
-22.83%
Earnings per share change (TTM)
69.17%
3-year revenue growth (CAGR)
-26.34%
10-year revenue growth (CAGR)
13.72%
3-year earnings per share growth (CAGR)
57.78%
10-year earnings per share growth (CAGR)
-5.61%
AMRN News
AllArticlesVideos
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
GlobeNewsWire·3 days ago
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewsWire·2 months ago
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Amarin Corporation stock?
Amarin Corporation (AMRN) has a market cap of $335M as of June 27, 2025.
What is the P/E ratio for Amarin Corporation stock?
The price to earnings (P/E) ratio for Amarin Corporation (AMRN) stock is 0 as of June 27, 2025.
Does Amarin Corporation stock pay dividends?
No, Amarin Corporation (AMRN) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Amarin Corporation dividend payment date?
Amarin Corporation (AMRN) stock does not pay dividends to its shareholders.
What is the beta indicator for Amarin Corporation?
Amarin Corporation (AMRN) has a beta rating of 0.67. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.